These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29131575)

  • 21. Synthesis and in Vitro Antibacterial Evaluation of Novel 4-Substituted 1-Menthyl-1,2,3-triazoles.
    Khaligh P; Salehi P; Bararjanian M; Aliahmadi A; Khavasi HR; Nejad-Ebrahimi S
    Chem Pharm Bull (Tokyo); 2016; 64(11):1589-1596. PubMed ID: 27803470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
    Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
    Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
    Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
    J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design, synthesis, and biological evaluation of isatin derivatives as potential glycosyltransferase inhibitors.
    Wang Y; Chan FY; Sun N; Lui HK; So PK; Yan SC; Chan KF; Chiou J; Chen S; Abagyan R; Leung YC; Wong KY
    Chem Biol Drug Des; 2014 Dec; 84(6):685-96. PubMed ID: 24890564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
    Oefner C; Bandera M; Haldimann A; Laue H; Schulz H; Mukhija S; Parisi S; Weiss L; Lociuro S; Dale GE
    J Antimicrob Chemother; 2009 Apr; 63(4):687-98. PubMed ID: 19211577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, molecular docking, binding free energy calculation and molecular dynamics simulation studies of benzothiazol-2-ylcarbamodithioates as
    Jupudi S; Azam MA; Wadhwani A
    J Recept Signal Transduct Res; 2019 Jun; 39(3):283-293. PubMed ID: 31538846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens.
    Jarvest RL; Berge JM; Berry V; Boyd HF; Brown MJ; Elder JS; Forrest AK; Fosberry AP; Gentry DR; Hibbs MJ; Jaworski DD; O'Hanlon PJ; Pope AJ; Rittenhouse S; Sheppard RJ; Slater-Radosti C; Worby A
    J Med Chem; 2002 May; 45(10):1959-62. PubMed ID: 11985462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of indolyl-containing peptides as novel antibacterial agents targeting tryptophanyl-tRNA synthetase.
    Zhang S; Qiu X; Wang R; Sun L; Zhu Z; Shan G; Li Z
    Future Med Chem; 2020 May; 12(10):877-896. PubMed ID: 32312096
    [No Abstract]   [Full Text] [Related]  

  • 29. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
    Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
    Xiao ZP; Ma TW; Liao ML; Feng YT; Peng XC; Li JL; Li ZP; Wu Y; Luo Q; Deng Y; Liang X; Zhu HL
    Eur J Med Chem; 2011 Oct; 46(10):4904-14. PubMed ID: 21856050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).
    Song MX; Zheng CJ; Deng XQ; Sun LP; Wu Y; Hong L; Li YJ; Liu Y; Wei ZY; Jin MJ; Piao HR
    Eur J Med Chem; 2013 Feb; 60():376-85. PubMed ID: 23314051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel antibacterial agents with inhibitory activity against DNA polymerase III.
    Ali A; Aster SD; Graham DW; Patel GF; Taylor GE; Tolman RL; Painter RE; Silver LL; Young K; Ellsworth K; Geissler W; Harris GS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2185-8. PubMed ID: 11514166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and characterization of natural tropolones as inhibitors of the antibacterial target CapF from Staphylococcus aureus.
    Nakano K; Chigira T; Miyafusa T; Nagatoishi S; Caaveiro JM; Tsumoto K
    Sci Rep; 2015 Oct; 5():15337. PubMed ID: 26471247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopeptidomimetics derived from teixobactin have potent antibacterial activity against Staphylococcus aureus.
    Girt GC; Mahindra A; Al Jabri ZJH; De Ste Croix M; Oggioni MR; Jamieson AG
    Chem Commun (Camb); 2018 Mar; 54(22):2767-2770. PubMed ID: 29484340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.
    Hrast M; Anderluh M; Knez D; Randall CP; Barreteau H; O'Neill AJ; Blanot D; Gobec S
    Eur J Med Chem; 2014 Feb; 73():83-96. PubMed ID: 24384549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtual screening of antibacterial compounds by similarity search of Enoyl-ACP reductase (FabI) inhibitors.
    Asse Junior LR; Kronenberger T; Magalhães Serafim MS; Sousa YV; Franco ID; Valli M; Silva Bolzani VD; Monteiro GC; Bruno Prates JL; Kroon EG; Fernandes Mota BE; Santos Ferreira DD; de Oliveira RB; Maltarollo VG
    Future Med Chem; 2020 Jan; 12(1):51-68. PubMed ID: 31729258
    [No Abstract]   [Full Text] [Related]  

  • 37. Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF): experimental and computational characterization.
    Perdih A; Hrast M; Pureber K; Barreteau H; Grdadolnik SG; Kocjan D; Gobec S; Solmajer T; Wolber G
    J Comput Aided Mol Des; 2015 Jun; 29(6):541-60. PubMed ID: 25851408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of 8-hydroxyquinoline derivatives as potential antibiotics against Staphylococcus aureus.
    Lam KH; Gambari R; Lee KK; Chen YX; Kok SH; Wong RS; Lau FY; Cheng CH; Wong WY; Bian ZX; Chan AS; Tang JC; Chui CH
    Bioorg Med Chem Lett; 2014 Jan; 24(1):367-70. PubMed ID: 24269165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of (phenylureido)piperidinyl benzamides as prospective inhibitors of bacterial autolysin E from Staphylococcus aureus.
    Borišek J; Pintar S; Ogrizek M; Grdadolnik SG; Hodnik V; Turk D; Perdih A; Novič M
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1239-1247. PubMed ID: 30141354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
    Mitton-Fry MJ; Brickner SJ; Hamel JC; Brennan L; Casavant JM; Chen M; Chen T; Ding X; Driscoll J; Hardink J; Hoang T; Hua E; Huband MD; Maloney M; Marfat A; McCurdy SP; McLeod D; Plotkin M; Reilly U; Robinson S; Schafer J; Shepard RM; Smith JF; Stone GG; Subramanyam C; Yoon K; Yuan W; Zaniewski RP; Zook C
    Bioorg Med Chem Lett; 2013 May; 23(10):2955-61. PubMed ID: 23566517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.